News Search Results
Sep 04, 2025, 05:00 ET Rapid Food Safety Testing Market worth $31.22 billion by 2030 - Exclusive Report by MarketsandMarkets™
biotechnology to express desired traits such as
More news about: MarketsandMarkets
Sep 03, 2025, 19:00 ET Nektar Therapeutics to Participate in Two Investor Conferences in September
conferences, please reach out to your respective representative. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Sep 03, 2025, 16:09 ET PLPC-DB™: Non-Cellular Oncology Immunotherapy with STIP-NAM Traceability, Entering a Global Acquisition Window.
for immediate acquisition, subject to due diligence and binding agreements. About OGRD AllianceOGRD Alliance is a global biotechnology group focused on advancing next-generation immunology platforms. With over a decade of research and a strong international regulatory framework,
More news about: OGRD Alliance
Sep 03, 2025, 14:00 ET BioFactura Launches Capitol Biologics - New CDMO Division to Accelerate Biologics Development from Concept to Clinic
Organization (CDMO) division dedicated to supporting the process development, early‑phase clinical manufacturing, and analytical needs of emerging biotechnology companies and U.S. government agencies. Strategically located in the BioHealth Capital Region, Capitol Biologics combines technical excellence,
More news about: BioFactura
Sep 03, 2025, 13:38 ET Seven Rubin and Rudman Partners Named to 2025 Lawdragon 500 Leading Global Real Estate Lawyers
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Sep 03, 2025, 11:43 ET Liebherr unveils New High-Performance refrigerators and freezers for use in research applications
The new series is specifically designed to meet the rigorous demands of biotechnology and pharmaceutical research environments. With a seamless chrome-nickel steel interior, these refrigerators and freezers offer exceptional durability,
More news about: Liebherr Appliances USA
Sep 03, 2025, 10:30 ET GMP Cell Therapy Consumables Market to Reach USD 114.4 Million by 2035, with CAGR 28.9% Driven by Advanced Cell Therapy and Biopharmaceutical Innovation | Vantage Market Research
medicine initiatives. Brazil is a key growth driver with expanding biopharma infrastructure. Increasing investment in biotechnology, medical research, and hospital-based cell therapy programs is strengthening opportunities for GMP consumables in the region. What Role
More news about: Vantage Market Research
Sep 03, 2025, 10:15 ET Swine Influenza Vaccines Market Projected to Reach USD 750 Billion by 2033 Driven by Advancements in Animal Health, Rising Swine Population - Market Research Intellect
Growing global demand for pork products fuels the need for healthier and more productive livestock, thereby increasing vaccine usage. Advances in biotechnology, such as recombinant DNA technology and mRNA platforms, open pathways for more effective, long-lasting vaccines. The integration of vaccines with
More news about: Market Research Intellect
Sep 03, 2025, 10:15 ET Rotavirus Vaccine Market Is Projected to Reach USD 3.5 Billion by 2033 Driven by Rising Immunization Programs and Increasing Healthcare Awareness - Market Research Intellect
impactful in low-resource settings, where storage and transportation challenges are significant barriers. Additionally, collaborations between biotechnology firms and healthcare organizations are accelerating clinical trials to expand product portfolios. The focus on developing combination vaccines that
More news about: Market Research Intellect
Sep 03, 2025, 10:10 ET Heterocyclic and Fluoro Organic Compounds Market to Reach $1,213.5 Million by 2035, Growing at 7.2% CAGR - Vantage Market Research
in laboratory research, pharmaceutical development, and chemical synthesis underpins this leadership. Reagents are integral to drug screening, biotechnology research, and high-purity compound production. Growing investments in R&D across pharmaceuticals, electronics, and agrochemicals are expected
More news about: Vantage Market Research
Sep 03, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Sep 03, 2025, 09:50 ET Pearl Meyer Adds Managing Director Will Cockle To Its Growing Technology Executive Compensation Practice
specializes in the technology and life sciences sectors, with a focus on software, emerging technologies, fintech, clean energy, and biotechnology. A frequent speaker at industry conferences on compensation and corporate governance trends, he holds a BSBA from Washington
More news about: Pearl Meyer
Sep 03, 2025, 09:02 ET Cellcosmet Unveils Next-Generation Brightening Duo for Complete Hyperpigmentation Defense
formulas in accordance to exacting, rigorous specifications and in keeping with the most recent scientific discoveries. Cellcosmet's command of biotechnology and expertise in cellular and microbiome science as well as botanical and marine ingredients enable the brand to formulate exceptional product offerings
More news about: Cellcosmet
Sep 03, 2025, 09:00 ET Cizzle Bio CEO Bill Behnke Named by CXO Outlook® as "Most Inspiring Business Leader 2025" for Advancing Breakthrough Early Cancer Detection Blood Tests
SAN ANTONIO, Sept. 3, 2025 /PRNewswire/ -- Cizzle Bio, Inc., a biotechnology company advancing innovative biomarker blood tests for early detection of lung and gastric cancers, announced today that its founder and CEO,
More news about: Cizzle Bio
Sep 03, 2025, 08:34 ET Coya Therapeutics to Participate at Upcoming September Investor Conferences
Sept. 3, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces the
More news about: Coya Therapeutics, Inc.
Sep 03, 2025, 08:30 ET Patient Recruitment: Digital, Design, Data and Dedicated Support to Reach the Unreachable, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 03, 2025, 08:30 ET Overcoming IPF and Other Rare Respiratory Disease Clinical Trial Challenges, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 03, 2025, 08:00 ET Monod Bio Receives $1.5M Grant to Develop NovoBodies™ for Next-Generation Tuberculosis Diagnostics
Monod Bio, a biotechnology startup and spinout from the University of Washington's Institute for Protein Design, announced today that it has received
More news about: Monod Bio
Sep 03, 2025, 08:00 ET LenioBio partners with AffinityAI to accelerate discovery of novel complex proteins through AI-guided design and high-throughput cell-free expression
therapeutics, combining cutting-edge AI design with scalable, cell-free expression technology. About LenioBio LenioBio GmbH is a biotechnology company pioneering cell-free protein expression with its ALiCE® platform, enabling rapid discovery, development, and scalable production of proteins
More news about: LenioBio
Sep 03, 2025, 08:00 ET Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease
andelynbio.com. About Tern Therapeutics TERN THERAPEUTICS is a privately held biotechnology company founded in 2023 with a new vision for speeding the development of transformative, one-time gene therapy medicines for rare diseases. Guided
More news about: Andelyn Biosciences
Sep 03, 2025, 08:00 ET Global Bio Conference 2025 kicks off in Seoul, charting biotech's future
Furthermore, a mentoring program, "Mentoring for Bio Youths," will be held to inspire and guide young talent who will lead the next generation of biotechnology. Minister Oh Yu-kyoung emphasized that GBC is not only a platform for global regulatory dialogue but also a critical step toward positioning
More news about: The Korea Herald
Sep 03, 2025, 07:15 ET SpliSense Reports Positive Results from Phase 2 Study of SPL84 in Cystic Fibrosis
Sept. 3, 2025 /PRNewswire/ -- SpliSense, a clinical-stage biotechnology company developing transformative RNA-based therapies for pulmonary diseases, today announced positive results from SPL84-002, its ongoing global
More news about: SpliSense
Sep 03, 2025, 07:08 ET VLCC Unveils The Great Indian Beauty Festival 2025 - India's Biggest Beauty Celebration of the Year
booster powered by polynucleotides and the Hymagic™-4D hyaluronic acid complex for deep hydration and tissue repair, and AnteAGE MD®, a breakthrough biotechnology treatment that uses stem cell-derived growth factors and cytokines to promote skin health and rejuvenation. Speaking on the occasion, Taniya
More news about: VLCC
Sep 03, 2025, 07:00 ET Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases
Sept. 3, 2025 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma, the Company), a clinical-stage biotechnology company focused on developing next-generation siRNA therapeutics, today announced that it has entered into an additional strategic collaboration
More news about: Argo Biopharmaceutical Co., Ltd.
Sep 03, 2025, 06:30 ET Biotechnology Market is Estimated to Reach USD 6.64 Trillion by 2032 | SkyQuest Technology Consulting
LimitedBiotechnology Market Segmental Analysis Global biotechnology market is segmented by technology, cell type, therapy type, therapeutic area, and end user. By therapeutic area, the oncology segment dominated the global biotechnology market in 2024
More news about: SkyQuest Technology